Bio:

Professor Vihandha (Vi) Wickramasinghe’s research interests lie in understanding the molecular basis of how RNA is selectively processed and exported from the nucleus into the cytoplasm and how deregulation of these processes contributes to human cancer.  Vi undertook PhD and postdoctoral studies at the University of Cambridge (2003-2016). He was recruited to Australia on a veski Innovation Fellowship in 2016 to start his laboratory at the Peter MacCallum Cancer Centre. His laboratory moved to the Walter and Eliza Hall Institute in November 2024. He is the inaugural Moderna Australia Fellow, and has recently spun out a company, exteRNA, to further develop first in-class inhibitors of mRNA export to treat cancer.